Targeting cellular structures called nuclear speckles could be a completely new approach for treating proteinopathies—diseases driven by abnormal accumulation of misfolded proteins—such as Alzheimer’s, Parkinson’s and prion diseases, according to new research published in Nature Communications and led by the University of Pittsburgh.
This article was originally published on MedicalXpress.com